About Webinar

In India, the incidence of epithelial ovarian cancer is estimated to be around 5.2 per 100,000 women. It is the seventh leading cause of cancer-related deaths among women. Worldwide, epithelial ovarian cancer is the fifth most common cancer among women, with an estimated 296,000 new cases and 186,000 deaths in 2018. It is the leading cause of death from Gynaecological cancers.

In this webinar, we will discuss the Genetics in epithelial ovarian cancer, current landscape of PARP inhibitors in the treatment of ovarian cancer and explore the potential future directions for this therapeutic approach. We hope that this webinar will provide you with a better understanding of PARP inhibitors and their potential role in the effective treatment of ovarian cancer.


E-Certificate will be provided to all the participants.

To get connected with eminent oncology professionals.

To interact with experts and gain knowledge.

Who Can Attend ?

  • Practitioners
  • Pathologist
  • Medical Oncologist
  • Surgical Oncologist
  • Radiation Oncologist
  • Gynaecologist


Dr. Sambit K Mohanty,

Senior Oncologic Surgical and Molecular Pathologist and Head of Clinical Research
CORE Diagnostics, New Delhi, India

Topic : Genetics in epithelial ovarian cancer: Focus on BRCA genes and Homologous recombination deficiency

Dr. Sourav Mishra,
Associate Professor

Department of Molecular Oncology/ Haematology
AIIMS, Bhubaneshwar, India

Topic : Maintenance therapy with PARP inhibitors in epithelial ovarian cancer


Registration Closed ...

For More Details Contact

Mr. Sambit Kumar

+91 6369025361 / +91 9345907121